Previous neuronal population modeling studies have revealed that pathological differences in E-I ratio across brain regions, determined by amyloid- and tau-protein distribution patterns, can explain AD-like neurophysiological signatures, such as spectral slowing (Alexandersen et al. 2023; Ranasinghe et al. 2022; Stefanovski et al. 2019). Here, MAPT is linked to Alzheimer disease.